Skip to content

FP7H2020HORIZON

Stichting het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis

Country
NLNetherlands
Defence projects
0
Projects, all programmes
139
As coordinator
49
EU contribution (CORDIS)
EUR 110,618,594
Active
2008 to 2026

Projects

139 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
HAP-PHENFrom haplotype to phenotype: a systems integration of allelic variation, chromatin state and 3D genome dataH20202015CoordinatorEUR 1,500,000
APERIMAPERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapyH20202015ParticipantEUR 279,000
MoTriColorMolecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor)H20202015ParticipantEUR 643,219
InflaMetMechanistic insights into the impact of tumor-associated neutrophils on metastatic breast cancerFP72014CoordinatorEUR 1,999,360
QuanTIQuantitative T cell ImmunologyFP72013ParticipantEUR 239,061
RNATRAINThe European non-coding RNA networkFP72013ParticipantEUR 247,861
SUPERSISTTowards clinical translation of new gene targeting technologies for correcting inherited mutations and empowering adoptive immunotherapy of cancerFP72013ParticipantEUR 573,744
COMBATCANCERCombination therapies for personalized cancer medicine.FP72013CoordinatorEUR 9,183,751
PLOIDYNETThe impact of chromosomal instability on health: Molecular causes and consequences of aneuploidyFP72013CoordinatorEUR 329,920
EUC²LIDEuropean Lead FactoryFP72013ParticipantEUR 401,449
MAMMOCAREBreast biopsy system guided by Positron Emission Mammography allowing real-time 3D visualization of tumour lesion and needle insertion guidance for higher sampling accuracy and efficiencyFP72013ParticipantEUR 42,072
Viral Host FactorsIdentification of Host Determinants for Virus Entry using a Haploid Genetic ApproachFP72013CoordinatorEUR 1,495,200
DR THERAPATDigital radiation therapy patientFP72013ParticipantEUR 784,120
ATECTAdvanced T-cell Engineered for Cancer TherapyFP72013ParticipantEUR 640,980
TRIPLE-BCIdentification and functional validation of drugable targets/pathways for triple negative breast cancerFP72013ParticipantEUR 96,384
INFRAFRONTIER-I3Development of mouse mutant resources for functional analyses of human diseases - Enhancing the translation of research into innovationFP72013ParticipantEUR 18,000
ENHREGExploring enhancers’ Achilles HeelFP72013CoordinatorEUR 2,176,840
BIOMEDBRIDGESBuilding data bridges between biological and medical infrastructures in EuropeFP72012ParticipantEUR 294,356
RAIDSRational molecular Assessments and Innovative Drug SelectionFP72012ParticipantEUR 537,573
CHROMATINPRINCIPLESPrinciples of Chromatin OrganizationFP72012CoordinatorEUR 2,495,080

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.